Save Skin Cancer Care — America is winning the war on skin cancer
Save Skin Cancer Care
A national campaign

America is winning the war on skin cancer. Don’t surrender now.

Skin cancer is the most common cancer in America, and we have learned how to beat it: caught early, melanoma’s five-year survival rate is 99%. A new Medicare proposal would cut the local care that makes early intervention possible. That’s why we are fighting to Save Skin Cancer Care!

The proposal is under review right nowEvery signature makes the record harder to ignoreSign the Community Statement The proposal is under review right nowEvery signature makes the record harder to ignoreSign the Community Statement The proposal is under review right nowEvery signature makes the record harder to ignoreSign the Community Statement The proposal is under review right nowEvery signature makes the record harder to ignoreSign the Community Statement
9,500

Americans diagnosed with skin cancer every single day

1 in 5

Americans will develop skin cancer in their lifetime

99% vs. 35%

melanoma’s five-year survival rate caught early vs. caught late

3.3 million

Americans battle this cancer every year

What CMS proposed

A $285 million cut aimed at the front lines of skin cancer care

In July 2026, the agency that runs Medicare proposed its 2027 payment rule. For dermatology, the rule stacks three cuts into one: a lower baseline rate, a rewritten formula for clinic overhead, and half payment for procedures done the same day as an exam. Together they would take roughly $285 million a year away from dermatology — about a third of all Medicare payment reductions across every medical specialty, even though dermatology accounts for less than 3% of Medicare Part B spending.

This is not a general belt-tightening that happens to touch dermatologists. About 91% of the dermatology codes CMS targeted are directly used to find and treat skin cancer. And the cuts run so deep that common procedures like biopsies would pay less than they cost to perform.

This cut is aimed at cancer care

91%

of the dermatology codes CMS targeted are used to find and treat skin cancer.

$285M

in Medicare cuts absorbed by dermatology alone

72%

of dermatologists face cuts greater than 15%

Below cost

what routine biopsies would pay under the rule

For policy readers: the details+

The CY2027 Medicare PFS proposed rule cuts dermatology through three mechanisms. (1) Conversion factor: −1.68% for non-QP clinicians ($32.84). (2) Modifier 25: a 50% payment reduction for procedures performed the same day as a separately identifiable E/M visit, despite a 2021 OIG review finding dermatologists generally bill Modifier 25 correctly and RUC processes having already removed overlapping costs. Under the 50% reduction, reimbursement falls below CMS’ own calculated direct practice expense (about −$14.76 per lesion shave, −$11.83 per tangential biopsy, −$13.10 per punch biopsy). (3) Practice expense: elimination of the Indirect Practice Cost Index (IPCI) in favor of a uniform formula; the Medicare-commissioned 2018 RAND analysis warned that removing specialty-specific inputs would “likely distort payments for specialties that have more expensive PE structures” and modeled a 27% PE RVU cut for dermatology; RAND also documented dermatology’s building and occupancy costs at roughly twice those of primary care. CMS estimates a 9% specialty impact from the rule alone, roughly 11% with conversion factor changes, and client modeling projects 15% to 18% fully phased in. In 14 states the cuts would drop Medicare reimbursement below Medicaid rates.

Why a billing rule reaches your skin check

The visit being cut in half is the one that catches cancer

Here is how skin cancer gets caught today — and exactly where the proposal breaks it. Keep scrolling.

STEP 01

One exam

A patient comes in for a routine skin check. One visit, one drive.

STEP 02

A spot is found

The dermatologist sees a suspicious lesion during the exam.

STEP 03

Biopsied on the spot

Same visit, same room. No second appointment, no second drive.

STEP 04

Answers within days

Caught at the stage where melanoma’s five-year survival is 99%.

UNDER THE PROPOSAL

That same-day biopsy pays only half.

Paying half pushes biopsies to a second appointment, weeks later. With cancer, weeks matter.

01 / 05

14 states where Medicare payment for skin cancer care would fall below Medicaid

Where it lands first

In 14 states, Medicare would pay less than Medicaid

Only about a third of dermatologists can afford to see Medicaid patients now; if Medicare rates sink below that, seniors on Medicare will face the same long waits and closed doors.

Practices that close or sell to hospital systems don’t make care cheaper, either: the same visit in a hospital department costs Medicare and taxpayers more. Federal analysts found that this kind of shift added $615 million in Medicare spending over five years.

New: Poll data — see what Americans think of the cuts →
Who gets hurt

The people who can least afford a missed melanoma

Skin cancer does not strike evenly. For the Americans below, the difference between an early diagnosis and a late one is the difference between a quick outpatient procedure and a fight for survival.

65+

Older Americans

Most skin cancer cases occur in Americans 65 and older — the very people who rely on Medicare.

88%

Rural communities

of rural U.S. counties have no dermatologist at all — and rural communities are where clinic closures hit first.

~400%

Military and veterans

Melanoma incidence among veterans is nearly four times higher than for non-veterans; military pilots face an 87% higher melanoma rate.

70%

Black Americans

More likely to be diagnosed late, with a five-year melanoma survival rate of just 70%.

Has early detection saved someone you love? Share your story →

The stakes

Early beats late. Every time, in every way.

Fifty years of progress got America’s melanoma survival rate from 82% to 99% and reduced treatment costs. The screening, biopsies, and treatment that dermatologists deliver in local communities did that work; they perform nearly all of the nation’s skin cancer procedures.

Melanoma five-year survival

Caught early 99%
Caught after it spreads 35%

Caught early

<$1,000

Usually a single office procedure.

250×

the cost when caught late

Caught after it spreads

>$250,000

Advanced treatment, per patient — a bill that lands on families and taxpayers.

What we’re asking

Three fixes, all within CMS’ power

01

Withdraw the same‑day cut

Withdraw the 50% payment cut for same-day procedures, so patients can keep getting a suspicious spot checked and biopsied in one visit.

02

Pay what care actually costs

Keep overhead payment tied to what care actually costs to deliver, rather than a one-size-fits-all formula the government’s own researchers warned against.

03

Index updates to inflation

Tie Medicare payment updates to inflation, so this fight doesn’t have to be refought every year.

About the campaign

Who we are

Save Skin Cancer Care is a national campaign of dermatologists, clinicians, patients, and communities who believe the fight against America’s most common cancer should not be defunded just as we’re winning it. We bring the evidence, the economics, and the voices of the people early detection has saved.

Read and sign the Community Statement →

The proposal is under review right now. So is your voice.

The cut is a draft, currently under review by federal health officials, and the government is accepting public comments. Every signature and every comment makes the record harder to ignore. Once the rule is final, it is too late.

Sign the Community Statement Share your story
Americans diagnosed with skin cancer since you opened this page: 0